melatonin has been researched along with Colitis, Mucous in 31 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin can be used as part of the treatment of IBS, particularly in patients with constipation-predominant IBS." | 9.17 | Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women. ( Chojnacki, C; Chojnacki, J; Klupińska, G; Lokieć, K; Pawłowicz, M; Walecka-Kapica, E; Winczyk, K, 2013) |
| "Compared with placebo, melatonin taken for two weeks significantly decreased mean abdominal pain score (2." | 9.11 | Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. ( Gwee, KA; Ho, KY; Leng, PH; Moochhala, SM; Song, GH, 2005) |
| "To determine the potential therapeutic effects of melatonin in irritable bowel syndrome (IBS)." | 9.11 | Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. ( Gwee, KA; Ho, KY; Lu, WZ; Moochhalla, S, 2005) |
| "Melatonin (MT) exerts a beneficial action in the treatment of many diseases, among them also in irritable bowel syndrome (IBS)." | 7.76 | Evaluation of urinary 6-hydroxymelatonin sulphate excretion in women at different age with irritable bowel syndrome. ( Brzozowski, T; Chojnacki, C; Chojnacki, J; Konturek, S; Smigielski, J; Wisniewska-Jarosinska, M, 2010) |
| "To evaluate melatonin (MEL) secretion and its metabolism to 6-hydroxymelatonin sulfate (6HMS) in patients with irritable bowel syndrome (IBS)." | 7.75 | [Melatonin secretion and metabolism in patients with irritable bowel syndrome]. ( Chojnacki, J; Harasiuk, A; Moskwa-Fortuna, A; Stepień, A; Wisniewska-Jarosińska, M, 2009) |
| "In patients with sleep disorders, significant improvement in sleep parameters, including subjective sleep quality, sleep latency, sleep duration, sleep efficiency, and daytime dysfunction, was observed, while in patients without sleep disorders, there was no significant improvement in sleep parameters." | 7.30 | The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study. ( Abbasian, S; Faghih Dinevari, M; Jabbaripour Sarmadian, A; Jafarzadeh, F; Nikniaz, Z; Riazi, A, 2023) |
| "Melatonin was found to play an important role in gastrointestinal smooth muscle motility." | 7.01 | The efficacy of exogenous melatonin supplement in ameliorating irritable bowel syndrome severity: A meta-analysis of randomized controlled trials. ( Chen, KH; Chen, TY; Chen, YW; Cheng, YS; Chu, CS; Hsu, CW; Hsu, CY; Liang, CS; Lin, PY; Su, KP; Sun, CK; Tseng, PT; Wu, MK; Wu, YC; Yeh, PY; Zeng, BS; Zeng, BY, 2023) |
| "Melatonin is a powerful antioxidant that resists oxidative stress due to its capacity to directly scavenge reactive species, to modulate the antioxidant defense system by increasing the activities of antioxidant enzymes, and to stimulate the innate immune response through its direct and indirect actions." | 6.55 | Melatonin's role as a co-adjuvant treatment in colonic diseases: A review. ( Alatorre-Jiménez, MA; Antoñanzas-Lombarte, Á; Buisac-Ramón, C; Castán-Ruiz, S; Esteban-Zubero, E; García, JJ; López-Pingarrón, L; Ochoa-Moneo, P; Reiter, RJ; Rivas-Jiménez, M; Tan, DX, 2017) |
| "Melatonin treatment has an extremely wide margin of safety though it may cause minor adverse effects, such as headache, rash and nightmares." | 6.50 | Melatonin for the treatment of irritable bowel syndrome. ( Ho, KY; Siah, KT; Wong, RK, 2014) |
| "Melatonin plays a beneficial role in gut motility and immunity." | 5.56 | Increased Expression of Colonic Mucosal Melatonin in Patients with Irritable Bowel Syndrome Correlated with Gut Dysbiosis. ( Duan, L; He, M; Liu, Z; Pei, F; Sun, Q; Wang, B; Wei, H; Zhang, J; Zhang, L; Zhu, S, 2020) |
| "Melatonin can be used as part of the treatment of IBS, particularly in patients with constipation-predominant IBS." | 5.17 | Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women. ( Chojnacki, C; Chojnacki, J; Klupińska, G; Lokieć, K; Pawłowicz, M; Walecka-Kapica, E; Winczyk, K, 2013) |
| "Compared with placebo, melatonin taken for two weeks significantly decreased mean abdominal pain score (2." | 5.11 | Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. ( Gwee, KA; Ho, KY; Leng, PH; Moochhala, SM; Song, GH, 2005) |
| "To determine the potential therapeutic effects of melatonin in irritable bowel syndrome (IBS)." | 5.11 | Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. ( Gwee, KA; Ho, KY; Lu, WZ; Moochhalla, S, 2005) |
| "Melatonin (MT) exerts a beneficial action in the treatment of many diseases, among them also in irritable bowel syndrome (IBS)." | 3.76 | Evaluation of urinary 6-hydroxymelatonin sulphate excretion in women at different age with irritable bowel syndrome. ( Brzozowski, T; Chojnacki, C; Chojnacki, J; Konturek, S; Smigielski, J; Wisniewska-Jarosinska, M, 2010) |
| "To evaluate melatonin (MEL) secretion and its metabolism to 6-hydroxymelatonin sulfate (6HMS) in patients with irritable bowel syndrome (IBS)." | 3.75 | [Melatonin secretion and metabolism in patients with irritable bowel syndrome]. ( Chojnacki, J; Harasiuk, A; Moskwa-Fortuna, A; Stepień, A; Wisniewska-Jarosińska, M, 2009) |
| "The purpose of the study was to evaluate the clinical effectiveness of melatonin (melaxen, Unipharm, USA), and its influence on the ultrastructural and histological features on the colon mucosa (CM) in patients with irritable bowel syndrome (IBS) corresponding to Rome criteria II." | 3.73 | [Irritated bowel syndrome: clinicomorphological aspects of treatment with melaxen]. ( Komarov, FI; Malinovskaia, NK; Raĭkhlin, NT; Rapoport, SI; Rumiantseva, AI; Voznesenskaia, LA, 2006) |
| "In patients with sleep disorders, significant improvement in sleep parameters, including subjective sleep quality, sleep latency, sleep duration, sleep efficiency, and daytime dysfunction, was observed, while in patients without sleep disorders, there was no significant improvement in sleep parameters." | 3.30 | The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study. ( Abbasian, S; Faghih Dinevari, M; Jabbaripour Sarmadian, A; Jafarzadeh, F; Nikniaz, Z; Riazi, A, 2023) |
| "Melatonin was found to play an important role in gastrointestinal smooth muscle motility." | 3.01 | The efficacy of exogenous melatonin supplement in ameliorating irritable bowel syndrome severity: A meta-analysis of randomized controlled trials. ( Chen, KH; Chen, TY; Chen, YW; Cheng, YS; Chu, CS; Hsu, CW; Hsu, CY; Liang, CS; Lin, PY; Su, KP; Sun, CK; Tseng, PT; Wu, MK; Wu, YC; Yeh, PY; Zeng, BS; Zeng, BY, 2023) |
| "The melatonin treatment of the control subjects caused an increase in CTT (mean+/-SD) from 27." | 2.74 | The effects of melatonin on colonic transit time in normal controls and IBS patients. ( Gwee, KA; Ho, KY; Lu, WZ; Song, GH, 2009) |
| "Melatonin is a powerful antioxidant that resists oxidative stress due to its capacity to directly scavenge reactive species, to modulate the antioxidant defense system by increasing the activities of antioxidant enzymes, and to stimulate the innate immune response through its direct and indirect actions." | 2.55 | Melatonin's role as a co-adjuvant treatment in colonic diseases: A review. ( Alatorre-Jiménez, MA; Antoñanzas-Lombarte, Á; Buisac-Ramón, C; Castán-Ruiz, S; Esteban-Zubero, E; García, JJ; López-Pingarrón, L; Ochoa-Moneo, P; Reiter, RJ; Rivas-Jiménez, M; Tan, DX, 2017) |
| "Melatonin treatment has an extremely wide margin of safety though it may cause minor adverse effects, such as headache, rash and nightmares." | 2.50 | Melatonin for the treatment of irritable bowel syndrome. ( Ho, KY; Siah, KT; Wong, RK, 2014) |
| "Melatonin is an endogenous indoleamine, produced mainly by the pineal gland." | 2.47 | Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. ( Amirian, I; Gögenur, I; Reiter, RJ; Rosenberg, J; Wilhelmsen, M, 2011) |
| "The fecal microbiota during IBS symptom exacerbation exhibited significant differences in the phylogenic pattern and short-chain fatty acid compared with fecal samples during defecation when symptoms were not exacerbated." | 1.72 | Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation. ( Fukuda, S; Fukudo, S; Gotoh, Y; Hayashi, T; Kasahara, Y; Kawashima, J; Kurokawa, K; Mori, H; Nakamura, K; Sato, Y; Tanaka, Y; Yamashita, R, 2022) |
| "Melatonin plays a beneficial role in gut motility and immunity." | 1.56 | Increased Expression of Colonic Mucosal Melatonin in Patients with Irritable Bowel Syndrome Correlated with Gut Dysbiosis. ( Duan, L; He, M; Liu, Z; Pei, F; Sun, Q; Wang, B; Wei, H; Zhang, J; Zhang, L; Zhu, S, 2020) |
| "Melatonin could inhibit WAS-induced fecal output pellets by inactivating the 5-HT pathway, may interact with calcium channel and inhibit the influx of calcium." | 1.39 | The inhibitory effect of melatonin on colonic motility disorders induced by water avoidance stress in rats. ( Liang, CB; Luo, HS; Tan, W; Xia, H; Zhou, W, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (38.71) | 29.6817 |
| 2010's | 13 (41.94) | 24.3611 |
| 2020's | 6 (19.35) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, Y | 1 |
| Yamashita, R | 1 |
| Kawashima, J | 1 |
| Mori, H | 1 |
| Kurokawa, K | 1 |
| Fukuda, S | 1 |
| Gotoh, Y | 1 |
| Nakamura, K | 1 |
| Hayashi, T | 1 |
| Kasahara, Y | 1 |
| Sato, Y | 1 |
| Fukudo, S | 1 |
| Chen, KH | 1 |
| Zeng, BY | 1 |
| Zeng, BS | 1 |
| Sun, CK | 1 |
| Cheng, YS | 1 |
| Su, KP | 1 |
| Wu, YC | 1 |
| Chen, TY | 1 |
| Lin, PY | 1 |
| Liang, CS | 1 |
| Hsu, CW | 1 |
| Chu, CS | 1 |
| Chen, YW | 1 |
| Yeh, PY | 1 |
| Wu, MK | 1 |
| Tseng, PT | 1 |
| Hsu, CY | 1 |
| Chojnacki, C | 4 |
| Konrad, P | 1 |
| Kaczka, A | 1 |
| Mędrek-Sochab, M | 1 |
| Chojnacki, M | 1 |
| Błońska, A | 1 |
| Faghih Dinevari, M | 1 |
| Jafarzadeh, F | 1 |
| Jabbaripour Sarmadian, A | 1 |
| Abbasian, S | 1 |
| Nikniaz, Z | 1 |
| Riazi, A | 1 |
| Kurin, M | 1 |
| Cooper, G | 1 |
| Wang, B | 1 |
| Zhu, S | 1 |
| Liu, Z | 1 |
| Wei, H | 1 |
| Zhang, L | 1 |
| He, M | 1 |
| Pei, F | 1 |
| Zhang, J | 1 |
| Sun, Q | 1 |
| Duan, L | 1 |
| Ng, QX | 1 |
| Soh, AYS | 1 |
| Lim, DY | 1 |
| Yeo, WS | 1 |
| Söderquist, F | 1 |
| Sundberg, I | 1 |
| Ramklint, M | 1 |
| Widerström, R | 1 |
| Hellström, PM | 1 |
| Cunningham, JL | 1 |
| Walecka-Kapica, E | 2 |
| Lokieć, K | 1 |
| Pawłowicz, M | 1 |
| Winczyk, K | 1 |
| Chojnacki, J | 4 |
| Klupińska, G | 2 |
| Mokwinska, M | 1 |
| Romanowski, M | 1 |
| Pawlowicz, M | 1 |
| Tan, W | 1 |
| Zhou, W | 1 |
| Luo, HS | 1 |
| Liang, CB | 1 |
| Xia, H | 1 |
| Siah, KT | 1 |
| Wong, RK | 2 |
| Ho, KY | 5 |
| Yang, C | 1 |
| Song, GH | 3 |
| Wong, J | 1 |
| Sebastián Domingo, JJ | 1 |
| Esteban-Zubero, E | 1 |
| López-Pingarrón, L | 1 |
| Alatorre-Jiménez, MA | 1 |
| Ochoa-Moneo, P | 1 |
| Buisac-Ramón, C | 1 |
| Rivas-Jiménez, M | 1 |
| Castán-Ruiz, S | 1 |
| Antoñanzas-Lombarte, Á | 1 |
| Tan, DX | 1 |
| García, JJ | 1 |
| Reiter, RJ | 2 |
| Lu, WZ | 2 |
| Gwee, KA | 3 |
| Ducrotté, P | 1 |
| Sood, MR | 1 |
| Chang, FY | 1 |
| Lu, CL | 1 |
| Stepień, A | 1 |
| Moskwa-Fortuna, A | 1 |
| Wisniewska-Jarosińska, M | 2 |
| Harasiuk, A | 1 |
| Radwan, P | 1 |
| Skrzydlo-Radomanska, B | 1 |
| Radwan-Kwiatek, K | 1 |
| Burak-Czapiuk, B | 1 |
| Strzemecka, J | 1 |
| Konturek, S | 1 |
| Brzozowski, T | 1 |
| Smigielski, J | 1 |
| Ghaith, O | 1 |
| El-Halabi, M | 1 |
| Hashash, JG | 1 |
| Sharara, AI | 1 |
| Mozaffari, S | 1 |
| Rahimi, R | 1 |
| Abdollahi, M | 1 |
| Wilhelmsen, M | 1 |
| Amirian, I | 1 |
| Rosenberg, J | 1 |
| Gögenur, I | 1 |
| Leng, PH | 1 |
| Moochhala, SM | 1 |
| Elsenbruch, S | 1 |
| Moochhalla, S | 1 |
| Saha, L | 1 |
| Malhotra, S | 1 |
| Rana, S | 1 |
| Bhasin, D | 1 |
| Pandhi, P | 1 |
| Komarov, FI | 1 |
| Raĭkhlin, NT | 1 |
| Rapoport, SI | 1 |
| Malinovskaia, NK | 1 |
| Voznesenskaia, LA | 1 |
| Rumiantseva, AI | 1 |
| Saad, RJ | 1 |
| Chey, WD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Understanding the Neurocognitive Effects of Fecal Microbiota Transplantation in Major Depressive Disorder Patients With and Without Irritable Bowel Syndrome[NCT05174273] | Phase 2/Phase 3 | 180 participants (Anticipated) | Interventional | 2022-04-06 | Recruiting | ||
| Effects of Perioperative Melatonin on Sleep, Pain, and Confusion After Joint Replacement Surgery[NCT01505465] | 50 participants (Actual) | Interventional | 2012-02-29 | Completed | |||
| The Therapeutic Effect of Melatonin in Pediatric Patients With Functional Dyspepsia[NCT04684199] | 14 participants (Actual) | Interventional | 2014-08-31 | Completed | |||
| Exploring the Mechanism of a Probiotic Combination VSL#3 in Irritable Bowel Syndrome: a Randomized Double Blind Placebo Controlled Study[NCT00786123] | 40 participants (Anticipated) | Interventional | 2006-05-31 | Completed | |||
| Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain[NCT01269671] | Phase 1 | 0 participants (Actual) | Interventional | 2011-01-31 | Withdrawn (stopped due to PI has left institution) | ||
| Melatonin and Ulcerative Colitis: A Pilot Clinical Trial[NCT00790478] | Phase 2 | 3 participants (Actual) | Interventional | 2009-01-31 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Sleep time change from 96 hours before surgery to 72 hours after surgery (NCT01505465)
Timeframe: 96 hours before surgery to 72 hours after surgery
| Intervention | minutes (Mean) |
|---|---|
| Study: Melatonin | 20 |
| Control: Placebo | -55 |
9 reviews available for melatonin and Colitis, Mucous
| Article | Year |
|---|---|
The efficacy of exogenous melatonin supplement in ameliorating irritable bowel syndrome severity: A meta-analysis of randomized controlled trials.
Topics: Dietary Supplements; Humans; Irritable Bowel Syndrome; Melatonin; Pain Measurement; Randomized Contr | 2023 |
Irritable bowel syndrome with diarrhea: Treatment is a work in progress.
Topics: Antidepressive Agents; Antidiarrheals; Cognitive Behavioral Therapy; Combined Modality Therapy; Diar | 2020 |
Melatonin for the treatment of irritable bowel syndrome.
Topics: Abdominal Pain; Animals; Dietary Supplements; Gastrointestinal Agents; Humans; Intestinal Mucosa; In | 2014 |
Melatonin's role as a co-adjuvant treatment in colonic diseases: A review.
Topics: Animals; Cell Proliferation; Colitis; Colitis, Ulcerative; Colonic Diseases; Enterocolitis, Necrotiz | 2017 |
Treatment of irritable bowel syndrome using complementary and alternative medicine.
Topics: Acupuncture Therapy; Aluminum Silicates; Animals; Clay; Complementary Therapies; Humans; Irritable B | 2009 |
Investigational agents for the irritable bowel syndrome.
Topics: Amines; Cyclohexanecarboxylic Acids; Drugs, Investigational; Female; Gabapentin; gamma-Aminobutyric | 2010 |
Implications of melatonin therapy in irritable bowel syndrome: a systematic review.
Topics: Animals; Gastrointestinal Motility; Gastrointestinal Tract; Humans; Irritable Bowel Syndrome; Melato | 2010 |
Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies.
Topics: Analgesics; Animals; Disease Models, Animal; Fibromyalgia; Humans; Irritable Bowel Syndrome; Male; M | 2011 |
Recent developments in the therapy of irritable bowel syndrome.
Topics: Animals; Antidepressive Agents; Calcium Channel Blockers; Corticotropin-Releasing Hormone; gamma-Ami | 2008 |
8 trials available for melatonin and Colitis, Mucous
| Article | Year |
|---|---|
The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study.
Topics: Abdominal Pain; Double-Blind Method; Humans; Iran; Irritable Bowel Syndrome; Melatonin; Quality of L | 2023 |
Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women.
Topics: Abdominal Pain; Aged; Constipation; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; | 2013 |
Influence of tianeptine on melatonin homeostasis and psychosomatic symptoms in patients with irritable bowel syndrome.
Topics: Adult; Antidepressive Agents, Tricyclic; Female; Homeostasis; Humans; Irritable Bowel Syndrome; Male | 2013 |
Melatonin regulation as a possible mechanism for probiotic (VSL#3) in irritable bowel syndrome: a randomized double-blinded placebo study.
Topics: Adult; Aged; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Male; Melatonin; Middle | 2015 |
The effects of melatonin on colonic transit time in normal controls and IBS patients.
Topics: Administration, Oral; Adult; Case-Control Studies; Colon; Cross-Over Studies; Double-Blind Method; F | 2009 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
Topics: Abdominal Pain; Adult; Defecation; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Ma | 2005 |
Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study.
Topics: Adult; Aged; Anxiety; Depressive Disorder; Double-Blind Method; Female; Gastrointestinal Agents; Hum | 2005 |
A preliminary study of melatonin in irritable bowel syndrome.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Free Radical Scavengers; Hu | 2007 |
14 other studies available for melatonin and Colitis, Mucous
| Article | Year |
|---|---|
Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation.
Topics: Butyrates; Diarrhea; Fatty Acids, Volatile; Feces; gamma-Aminobutyric Acid; Glutamine; Humans; Hydro | 2022 |
The role of serotonin in pathogenesis of unclassified irritable bowel syndrome.
Topics: Cyproheptadine; Humans; Hydroxyindoleacetic Acid; Irritable Bowel Syndrome; Melatonin; Serotonin | 2022 |
Increased Expression of Colonic Mucosal Melatonin in Patients with Irritable Bowel Syndrome Correlated with Gut Dysbiosis.
Topics: Animals; Diarrhea; Dysbiosis; Humans; Irritable Bowel Syndrome; Melatonin; Rats | 2020 |
Agomelatine, a novel therapeutic option for the management of irritable bowel syndrome.
Topics: Acetamides; Adolescent; Adult; Aged; Female; Humans; Hypnotics and Sedatives; Irritable Bowel Syndro | 2018 |
The Relationship Between Daytime Salivary Melatonin and Gastrointestinal Symptoms in Young Adults Seeking Psychiatric Care.
Topics: Adolescent; Adult; Anxiety Disorders; Circadian Rhythm; Comorbidity; Female; Humans; Irritable Bowel | 2019 |
The inhibitory effect of melatonin on colonic motility disorders induced by water avoidance stress in rats.
Topics: Acetylcholine; Animals; Colon; Defecation; Gastrointestinal Motility; Irritable Bowel Syndrome; Male | 2013 |
[Irritable bowel syndrome: the next-to-last that is being investigated].
Topics: Antidepressive Agents, Tricyclic; Biomarkers; Complementary Therapies; Diet; Dietary Carbohydrates; | 2016 |
[Irritable bowel syndrome: dietary and pharmacological therapeutic options].
Topics: Abdominal Pain; Analgesics; Anesthetics, Local; Anti-Bacterial Agents; Antidepressive Agents; Centra | 2009 |
Treatment approaches to irritable bowel syndrome.
Topics: Alprostadil; Anti-Bacterial Agents; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Child | 2009 |
[Melatonin secretion and metabolism in patients with irritable bowel syndrome].
Topics: Adult; Female; Gastrointestinal Motility; Humans; Irritable Bowel Syndrome; Male; Melatonin; Middle | 2009 |
Is melatonin involved in the irritable bowel syndrome?
Topics: Adult; Analysis of Variance; Case-Control Studies; Circadian Rhythm; Female; Humans; Irritable Bowel | 2009 |
Evaluation of urinary 6-hydroxymelatonin sulphate excretion in women at different age with irritable bowel syndrome.
Topics: Adult; Aged; Female; Humans; Irritable Bowel Syndrome; Melatonin; Middle Aged; Serotonin | 2010 |
Melatonin: a novel treatment for IBS?
Topics: Adaptation, Physiological; Humans; Irritable Bowel Syndrome; Melatonin; Mood Disorders; Polysomnogra | 2005 |
[Irritated bowel syndrome: clinicomorphological aspects of treatment with melaxen].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Biopsy; Colon; Female; Follow-Up Studies; Humans; Intesti | 2006 |